
Novo Nordisk owns 2 brands in our database. Browse the complete portfolio of Novo Nordisk subsidiaries and brands across various industries.
Company Type
public
Headquarters
Copenhagen, Denmark
Brand Portfolio
2 brands
Stock
NASDAQ: NVO

Owned by Novo Nordisk
Prescription diabetes medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.

Owned by Novo Nordisk
Prescription weight loss medication brand owned by Novo Nordisk, containing semaglutide as the active ingredient.
Novo Nordisk is a Danish multinational pharmaceutical company founded in 1923 by Harald Pedersen, headquartered in Copenhagen, Denmark. Under CEO Mike Doustdar, Novo Nordisk trades on NASDAQ (NVO) and is a global leader in diabetes care and obesity treatment. The company reported 2025 sales growth of 10% to DKK 309 billion with operating profit growth of 6%, forecasting 2026 adjusted sales growth of -5% to -13% due to pricing pressures and competition in the GLP-1 market.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Eli Lilly | USA | 2023 | Mass Market | North America | All Genders | |
| Eli Lilly | USA | 2022 | Mass Market | North America | Male |

Owned by Eli Lilly and Company
Prescription weight loss medication brand owned by Eli Lilly, containing tirzepatide as the active ingredient.

Owned by Eli Lilly and Company
Pharmaceutical brand of tirzepatide injection for type 2 diabetes treatment, owned by Eli Lilly and Company.
Market Positioning: Novo Nordisk competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Novo Nordisk maintains a diverse portfolio of 2 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Novo Nordiskprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Who makes your medications? Discover which corporations own the biggest pharmaceutical brands, from Ozempic to Tylenol, and how pharma M&A affects you.
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.